Create your account

Analyse episodes, create alerts, spot trends before they go mainstream

Already have an account? Sign in

Companies

Isomorphic Labs

Mentioned in 8 analyzed podcast episodes across 8 shows

A DeepMind spinoff company focused on AI-driven drug discovery and therapeutic development, leveraging proprietary versions of AlphaFold technology to tackle disease targets and accelerate pharmaceutical research. The company has partnered with major pharmaceutical firms like Novartis to apply its AI models to previously undruggable targets, and has demonstrated significant performance improvements on key drug discovery benchmarks. Podcasters discuss Isomorphic Labs as a notable example of how foundational AI research is being commercialized for real-world biomedical applications.

Episode Mentions

Moonshots with Peter Diamandis

Moonshots with Peter Diamandis · Feb 19, 2026

Ben Horowitz: xAI Executive Exodus, Apple's AI Crisis, The Pace of AI | #232

DeepMind subsidiary working on AI-driven scientific discovery and protein design

Recursive Self-Improvement (RSI) and AI Singularity TimelineXAI Executive Departures and ITAR RegulationsByteDance C-Dance 2.0 Video Generation Technology
View Analysis
Invest Like the Best with Patrick O'Shaughnessy

Invest Like the Best with Patrick O'Shaughnessy · Feb 18, 2026

Josh Kushner - Concentration and Conviction - [Invest Like the Best, EP.459]

AI company spun out from DeepMind with Thrive support; focused on drug discovery and disease curing

Concentrated portfolio strategy and conviction investingFounder-centric partnership model in venture capitalSmall team culture and organizational design
View Analysis
The a16z Show

The a16z Show · Feb 16, 2026

Novartis CEO Vasant Narasimhan on Transforming a 250-Year-Old Company

AI company partnering with Novartis on undruggable targets using AlphaFold3

Corporate transformation and spin-offsCell and gene therapy platformsRNA therapeutics and siRNA technology
View Analysis
"The Cognitive Revolution" | AI Builders, Researchers, and Live Player Analysis

"The Cognitive Revolution" | AI Builders, Researchers, and Live Player Analysis · Feb 14, 2026

Approaching the AI Event Horizon? Part 2, w/ Abhi Mahajan, Helen Toner, Jeremie Harris, @8teAPi

Announced predictive model doubling AlphaFold 3 performance on key drug discovery benchmarks

Recursive Self-ImprovementAI for Cancer TreatmentAutomated AI Research
View Analysis
Latent Space: The AI Engineer Podcast

Latent Space: The AI Engineer Podcast · Feb 12, 2026

🔬Beyond AlphaFold: How Boltz is Open-Sourcing the Future of Drug Discovery

DeepMind spinoff that kept AlphaFold 3 proprietary for commercial drug discovery applications

AlphaFold evolution and impactProtein structure predictionOpen-source AI model development
View Analysis
My First Million

My First Million · Jan 19, 2026

Story Of The Most Important Founder You've Never Heard Of

Artificial General Intelligence (AGI)Protein folding and drug discoveryGame-based AI training methodologies
View Analysis
Google DeepMind: The Podcast

Google DeepMind: The Podcast · Nov 28, 2025

AlphaFold: Grand Challenge to Nobel Prize with John Jumper

Using AlphaFold for drug design and small molecule discovery; applying structure prediction to therapeutic development

Protein Structure PredictionAlphaFold Architecture and EvolutionDrug Discovery and Development
View Analysis
Lex Fridman Podcast

Lex Fridman Podcast · Jul 23, 2025

#475 – Demis Hassabis: Future of AI, Simulating Reality, Physics and Video Games

Spun out from DeepMind to apply AlphaFold-like systems to drug discovery and chemistry

AGI Timeline and DefinitionP vs NP Problem and Computational ComplexityProtein Folding and AlphaFold Architecture
View Analysis